Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. (December 2019)

Record Type:: Journal Article
Title:: Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. (December 2019)
Main Title:: Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval
Authors:: Turner, Erick H
Abstract:
Is Part Of:: Lancet. Volume 6:Number 12(2019)
Journal:: Lancet
Issue:: Volume 6:Number 12(2019)
Issue Display:: Volume 6, Issue 12 (2019)
Year:: 2019
Volume:: 6
Issue:: 12
Issue Sort Value:: 2019-0006-0012-0000
Page Start:: 977
Page End:: 979
Publication Date:: 2019-12
Subjects:: Psychiatry -- Periodicals
616.89
Journal URLs:: http://www.sciencedirect.com/science/journal/22150366 ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2215-0366(19)30394-3 ↗
Languages:: English
ISSNs:: 2215-0366
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.092000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19129.xml